Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06826755 · ClinicalTrials.gov registry record · NA

Melatonin Effects on Cardiovascular Disease Mechanisms in Midlife Women: A Randomized Clinical Trial

A NA study of Hypertension and Perimenopause, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
70
Enrollment target
1
Study location

NCT06826755 is a NA study of Hypertension and Perimenopause that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 70 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06826755, a NA study of Hypertension and Perimenopause, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
70 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research is to study the effects of 12 weeks of melatonin supplementation compared to placebo in women who are in the menopause transition (perimenopause) and have high blood pressure.

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Terry Naturally® melatonin 5mg SR

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2025-05-23
Est. Completion 2027-01
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT06826755

The ClinicalTrials.gov registry entry for NCT06826755 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (98% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT06826755 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT06826755 about?

NCT06826755 is a clinical study titled "Melatonin Effects on Cardiovascular Disease Mechanisms in Midlife Women: A Randomized Clinical Trial". The purpose of this research is to study the effects of 12 weeks of melatonin supplementation compared to placebo in women who are in the menopause transition (perimenopause) and have high blood pressure.

What is the current status of trial NCT06826755?

This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2025-05-23. Estimated completion is 2027-01.

What conditions does trial NCT06826755 study?

This clinical trial studies the following conditions: Hypertension, Perimenopause.

What interventions are being tested in trial NCT06826755?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Terry Naturally® melatonin 5mg SR (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06826755?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06826755 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.